Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) EBT: 2022-2023

Historic EBT for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$5.2 million.

  • Mainz Biomed N.V's EBT rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.66% up from last year.
  • Per Mainz Biomed N.V's latest filing, its EBT stood at -$5.2 million for Q4 2023, which was up 17.72% from -$6.3 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed N.V's EBT ranged from a high of -$5.2 million in Q4 2023 and a low of -$8.3 million during Q2 2023.
  • Moreover, its 2-year median value for EBT was -$6.4 million (2023), whereas its average is -$6.6 million.
  • The largest annual percentage gain for Mainz Biomed N.V's EBT in the last 5 years was 36.70% (2023), contrasted with its biggest fall of 18.92% (2023).
  • Mainz Biomed N.V's EBT (Quarterly) stood at -$8.2 million in 2022, then surged by 36.70% to -$5.2 million in 2023.
  • Its EBT was -$5.2 million in Q4 2023, compared to -$6.3 million in Q3 2023 and -$8.3 million in Q2 2023.